| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/08/2001 | WO2001009160A1 Nucleic acid ligands to cd40ligand |
| 02/08/2001 | WO2001008714A1 Cartilage or bone matrix as a nucleic acid delivery vehicle |
| 02/08/2001 | WO2001008710A1 Gene expression with covalently modified polynucleotides |
| 02/08/2001 | WO2001008709A1 Sonoporation of tumors |
| 02/08/2001 | WO2001008708A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 02/08/2001 | WO2001008707A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 02/08/2001 | WO2001008702A2 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 02/08/2001 | WO2001008701A2 Invasive bacteria based viral vaccines |
| 02/08/2001 | WO2001008696A2 Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy |
| 02/08/2001 | WO2001008694A2 Direct arterial infiltration for production of vascular pathology |
| 02/08/2001 | WO2001008635A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2001008486A1 CoaA POLYPEPTIDES AND POLYNUCLEOTIDES AND METHODS THEREOF |
| 02/08/2001 | WO2000076540A3 Streptococcus pneumoniae proteins and vaccines |
| 02/08/2001 | WO2000075317A3 Compositions and methods for the treatment of tumor |
| 02/08/2001 | WO2000068261A3 Attenuated microorganisms for the treatment of infection |
| 02/08/2001 | WO2000067798A3 Enhanced delivery of nucleic acid-based drugs |
| 02/08/2001 | WO2000063406A3 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |
| 02/08/2001 | WO2000063230A3 49 human secreted proteins |
| 02/08/2001 | WO2000062816A3 Genetic tolerization |
| 02/08/2001 | WO2000062815A3 Novel pharmaceutical composition suitable for gene therapy |
| 02/08/2001 | WO2000061772A3 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/08/2001 | WO2000061756A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 02/08/2001 | WO2000059525A3 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 02/08/2001 | WO2000053773A3 Methods for mitochondrial gene therapy |
| 02/08/2001 | DE19936563A1 Tumorassoziiertes Antigen Tumor-associated antigen |
| 02/08/2001 | DE19935303A1 Oligonukleotide zur Inhibierung der Expression von humanem eg5 Oligonucleotides for inhibiting the expression of human Eg5 |
| 02/08/2001 | DE19935302A1 Konjugate und Verfahren zu deren Herstellung sowie deren Verwendung zum Transport von Molekülen über biologische Membranen Conjugates and methods for their preparation and their use for transporting molecules across biological membranes |
| 02/08/2001 | DE10019006A1 Neuartiger adenoviraler Vektor für den Gentransfer, seine Anwendung und seine Herstellung Novel adenoviral vector for gene transfer, its application and its preparation |
| 02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 02/08/2001 | CA2391348A1 Enhanced delivery via serpin enzyme complex receptor |
| 02/08/2001 | CA2381945A1 Mammalian adhesion protease peptides |
| 02/08/2001 | CA2380825A1 Basb116 dna and proteins from moraxella catarrhalis |
| 02/08/2001 | CA2380822A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380803A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380787A1 Microencapsulated nitric oxide synthase source |
| 02/08/2001 | CA2380631A1 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | CA2380545A1 Nucleic acid ligands to cd40ligand |
| 02/08/2001 | CA2380515A1 Polypeptides and polynucleotides from moraxella catarrhalis |
| 02/08/2001 | CA2380379A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 02/08/2001 | CA2380351A1 Basb126 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | CA2380018A1 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 02/08/2001 | CA2379832A1 Invasive bacteria-based viral vaccines |
| 02/08/2001 | CA2379663A1 Cartilage or bone matrix as a nucleic acid delivery vehicle |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2378331A1 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | CA2378182A1 Compositions and methods for the treatment of tumors |
| 02/07/2001 | EP1074625A2 DNA vaccine against feline immunodeficiency virus |
| 02/07/2001 | EP1074623A1 ABC transporter |
| 02/07/2001 | EP1074620A1 Monomeric protein of the TGF-beta family |
| 02/07/2001 | EP1074619A2 Promoter for neuropeptide FF and use thereof for therapy and diagnostics |
| 02/07/2001 | EP1074559A1 Peptide nucleic acids |
| 02/07/2001 | EP1074248A1 Delivery system for biological material |
| 02/07/2001 | EP1073760A1 Adenovirus mutants with deleted protease gene, complementing cell lines and corresponding vectors for gene transfer |
| 02/07/2001 | EP1073759A1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 02/07/2001 | EP1073758A1 Retroviral vectors including modified envelope escort proteins |
| 02/07/2001 | EP1073752A1 PROTEIN WITH THE AMINO ACID SEQUENCE OF DELTA 7 STEROL REDUCTASE,ISOLATED cDNA MOLECULE CODING FOR SAID PROTEIN, RECOMBINANT DNA VECTOR AND BIOLOGICALLY ACTIVECOMPOSITIONS CONTAINING SAID PROTEIN OR SAID cDNA MOLECULE |
| 02/07/2001 | EP1073751A2 Polypeptide with immunogenic properties and with a protein with modified biological functions |
| 02/07/2001 | EP1073749A2 Enhancing immune responses to genetic immunization by using a chemokine |
| 02/07/2001 | EP1073742A2 Human nucleic acid sequences of bladder tumour tissue |
| 02/07/2001 | EP1073738A2 Human k+ ion channel and therapeutic applications thereof |
| 02/07/2001 | EP1073737A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/07/2001 | EP1073733A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
| 02/07/2001 | EP1073729A2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073728A2 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073727A2 Human nucleic acid sequences from ovarian tumour tissue |
| 02/07/2001 | EP1073713A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae |
| 02/07/2001 | EP1073710A2 Non-stochastic generation of genetic vaccines and enzymes |
| 02/07/2001 | EP1073707A1 A process of making a compound by forming a polymer from a template drug |
| 02/07/2001 | EP1073683A1 G-csf receptor agonist antibodies and screening method therefor |
| 02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 02/07/2001 | EP1073669A2 Gcp |
| 02/07/2001 | EP1073471A1 Method of treating endotoxemia |
| 02/07/2001 | EP1073456A1 Compositions and methods for the prevention and treatment of cardiovascular diseases |
| 02/07/2001 | EP1073455A1 Compositions and methods for extending the action of clostridial neurotoxin |
| 02/07/2001 | EP1073442A1 Combination viral-based and gene-based therapy of tumors |
| 02/07/2001 | EP1073427A1 Periadventitial delivery device |
| 02/07/2001 | EP0943096A4 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
| 02/07/2001 | CN1283233A Variant loxP sequences and application of the same |
| 02/07/2001 | CN1283228A Polypeptide, their production method and use |
| 02/07/2001 | CN1283121A HIV-ITAT or derwatives thereof for prophylatic and therapeutic vacceination |
| 02/07/2001 | CN1283108A I (chlamydia) protein, gene sequence and uses thereof |
| 02/06/2001 | US6184371 Lactoferrin receptor genes of Moraxella |
| 02/06/2001 | US6184352 Adseverin protein |
| 02/06/2001 | US6184212 Antisense modulation of human mdm2 expression |
| 02/06/2001 | US6184211 Inhibition of DNA methyltransferase |
| 02/06/2001 | US6184202 Modulating apoptosis of a cell by administering an agent comprising a bh1 or bh2 domain capable of promoting or inhibiting formation of a complex of bcl-2:blc-2; bcl-xl:bcl-xl; bax:bax; and/or bcl-xl:bax |
| 02/06/2001 | US6184038 Transport proteins and their uses |
| 02/06/2001 | US6184035 Modulation of cellular differentiation in bone associated tissues; culturing muscles tissues under preferential oxygen environment and monitoring development |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | US6183991 Nucleotide and amino acid sequence; recombinant production of polypeptide; enhancing viability of cryopreserved sperm, sperm motility, and fertilization in assisted reproduction; contraceptives |
| 02/06/2001 | US6183988 Leukocyte-specific protein and gene, and methods of use thereof |
| 02/06/2001 | US6183780 May be used for the application of active substances whenever a certain lag-time before release is advantageous, such as in be the case of anti-asthmatics, anti-emetics, cardiotonics, vasodilators, anti-vertigo and anti-meniere. |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |
| 02/06/2001 | US6183734 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 02/05/2001 | CA2309313A1 Stimulation of the immune response by human dendritic cell manipulation |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007656A1 Antisense modulation of shp-1 expression |